Cetera Investment Advisers’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.13M	Buy	8,648 +338	+4%	+$168K	0.01%	1484
2025 Q4	$4.05M	Buy	8,310 +1,343	+19%	+$625K	﹤0.01%	1609
2025 Q3	$2.92M	Sell	6,967 -960	-12%	-$323K	﹤0.01%	1849
2025 Q2	$2.28M	Sell	7,927 -97	-1%	-$29K	﹤0.01%	1749
2025 Q1	$2.47M	Sell	8,024 -691	-8%	-$237K	﹤0.01%	1593
2024 Q4	$3.08M	Buy	8,715 +463	+6%	+$170K	0.01%	1342
2024 Q3	$2.96M	Buy	8,252 +2,085	+34%	+$704K	0.01%	1335
2024 Q2	$1.96M	Buy	6,167 +493	+9%	+$130K	﹤0.01%	1589
2024 Q1	$1.3M	Buy	5,674 +3,015	+113%	+$680K	﹤0.01%	1870
2023 Q4	$585K	Buy	2,659 +197	+8%	+$45.4K	﹤0.01%	1408
2023 Q3	$556K	Buy	2,462 +210	+9%	+$48.4K	﹤0.01%	1363
2023 Q2	$497K	Buy	2,252 +295	+15%	+$65.3K	﹤0.01%	1454
2023 Q1	$438K	Buy	1,957 +6	+0.3%	+$1.48K	﹤0.01%	1505
2022 Q4	$543K	Buy	1,951 +792	+68%	+$200K	0.01%	1328
2022 Q3	$243K	Buy	1,159 +203	+21%	+$45.4K	﹤0.01%	1403
2022 Q2	$225K	Buy	+956	New	+$194K	﹤0.01%	1604